Environment and wallet benefit from redispensing cancer pills

Redispensing cancer drugs reduces both environmental impact and medical costs, according to research from Radboudumc pharmacy published in JAMA Oncology. The annual savings could amount to tens of millions.
Cancer drugs as pills are not always used up by patients. The drugs are mostly expensive and environmentally damaging, both in production and (waste) disposal. In her PhD research, Lisa-Marie Smale of Radboudumc investigated whether these unused drugs can be collected and reissued. Does such an approach ultimately lead to lower environmental impact and costs?
Redispense medication
When redispensing medications, the quality must be guaranteed. Therefore, in this study the medications were packaged separately and fitted with a sensor, which registers whether returned medications were kept within the required temperature. Smale: “If packaging, temperature and expiration date are in order, the returned medications can be redispensed. For two years we investigated this procedure in cooperation with the pharmacies of four Dutch hospitals; Radboudumc, UMC Utrecht, Jeroen Bosch hospital and St Antonius hospital. Over a thousand patients who were taking oral cancer medications at home participated in the study during that period.”
Saving tens of millions
The results, published in JAMA Oncology, look promising. The investment in the method, such as packaging with a temperature sensor, amounts up to 37 euros per patient per year. This is offset by savings of 613 euros. Annually, this results in a net saving per patient of 576 euros. Smale: “In the Netherlands, we can save between 20 and 50 million euros annually with this redispensing of medication. Meanwhile, we have further optimized the process, making a net saving of 655 euros per patient possible. In the Netherlands, we have relatively low drug prices. If you look at the U.S., where the price of new drugs is over 300 percent higher, in principle much more money can be saved there.”
Large-scale consequence
Of all wasted medicine packaging, two-thirds could be reissued. Project leader Charlotte Bekker of Radboudumc says, “Based on the results, the study will be expanded to 14 hospitals. Again, we are looking at cancer pills. Reissue is only allowed in the context of a scientific study because of European rules. We hope that the approach can eventually be used nationwide, as well as for other drugs.”

Sustainability and social impact also benefit
“This approach is cost-effective for expensive drugs,” Smale says, “but ultimately there are other factors you want to consider, such as sustainability or social impact. Think of the environmental impact you can reduce by not destroying drugs but redispensing them; this can also be beneficial for drugs that are in short supply.”
Broad interest
The study published in JAMA Oncology is, to our knowledge, the first to examine drug redispensing with guaranteed quality. The topic is attracting strong interest, not only in the medical community but also beyond. Several parties are committed to make further expansion possible. In addition to the participating hospitals, the Dutch Association of Hospital Pharmacists (NVZA) is also closely involved. And it is part of the Green Deal objectives to make healthcare more sustainable. Smale: “We are happy to work with all parties to address and reduce the cost and environmental impact of wasted medicines.”

Read more →

Air cleaners don't stop you getting sick

Air filtration systems do not reduce the risk of picking up viral infections, according to new research from the University of East Anglia.
A new study published today reveals that technologies designed to make social interactions safer in indoor spaces are not effective in the real world.
The team studied technologies including air filtration, germicidal lights and ionisers.
They looked at all the available evidence but found little to support hopes that these technologies can make air safe from respiratory or gastrointestinal infections.
Prof Paul Hunter, from UEA’s Norwich Medical School, said: “Air cleaners are designed to filter pollutants or contaminants out of the air that passes through them.
“When the Covid pandemic hit, many large companies and governments — including the NHS, the British military, and New York City and regional German governments — investigated installing this type of technology in a bid to reduce airborne virus particles in buildings and small spaces.
“But air treatment technologies can be expensive. So it’s reasonable to weigh up the benefits against costs, and to understand the current capabilities of such technologies.”
The research team studied evidence about whether air cleaning technologies make people safe from catching airborne respiratory or gastrointestinal infections.

They analysed evidence about microbial infections or symptoms in people exposed or not to air treatment technologies in 32 studies, all conducted in real world settings like schools or care homes. So far none of the studies of air treatment started during the Covid era have been published.
Lead researcher Dr Julii Brainard, also from UEA’s Norwich Medical School, said: “The kinds of technologies that we considered included filtration, germicidal lights, ionisers and any other way of safely removing viruses or deactivating them in breathable air.
“In short, we found no strong evidence that air treatment technologies are likely to protect people in real world settings.
“There is a lot of existing evidence that environmental and surface contamination can be reduced by several air treatment strategies, especially germicidal lights and high efficiency particulate air filtration (HEPA). But the combined evidence was that these technologies don’t stop or reduce illness.
“There was some weak evidence that the air treatment methods reduced likelihood of infection, but this evidence seems biased and imbalanced.
“We strongly suspect that there were some relevant studies with very minor or no effect but these were never published.

“Our findings are disappointing — but it is vital that public health decision makers have a full picture.
“Hopefully those studies that have been done during Covid will be published soon and we can make a more informed judgement about what the value of air treatment may have been during the pandemic.”
This research was led by the University of East Anglia with collaborators at University College London, the University of Essex, the Norfolk and Norwich University Hospital Trust, and the University of Surrey.
It was funded by the National Institute for Health and Care Research Health Protection Unit in Emergency Preparedness and Response, led by Kings College London and UEA in collaboration with the UK Health Security Agency.

Read more →

Discovery of hemoglobin in the epidermis sheds new light on our skin's protective properties

Researchers have shown for the first time that hemoglobin, a protein found in red blood cells where it binds oxygen, is also present in the epidermis, our skin’s outermost body tissue. The study, which appears in the Journal of Investigative Dermatology, published by Elsevier, provides important insights into the properties of our skin’s protective external layer.
This research was driven by a curiosity about how the epidermis protects our delicate body from the environment and what unexpected molecules are expressed in the epidermis. Researchers discovered the hemoglobin ? protein in keratinocytes of the epidermis and in hair follicles. This unexpected evidence adds a new facet to the understanding of the workings of our skin’s defense mechanisms.
Lead investigator of the study Masayuki Amagai, MD, PhD, Department of Dermatology, Keio University School of Medicine, Tokyo, and Laboratory for Skin Homeostasis, RIKEN Center for Integrative Medical Sciences, Yokohama, explains: “The epidermis consists of keratinized stratified squamous epithelium, which is primarily composed of keratinocytes. Previous studies have identified the expression of various genes with protective functions in keratinocytes during their differentiation and formation of the outer skin barrier. However, other barrier-related genes escaped prior detection because of difficulties obtaining adequate amounts of isolated terminally differentiated keratinocytes for transcriptome analysis.”
Hemoglobin binds gases such as oxygen, carbon dioxide, and nitric oxide, and it is an iron carrier via the heme complex. These properties make epidermal hemoglobin a prime candidate for antioxidant activity and potentially other roles in barrier function.
Professor Amagai continues: “We conducted a comparative transcriptome analysis of the whole and upper epidermis, both of which were enzymatically separated as cell sheets from human and mouse skin. We discovered that the genes responsible for producing hemoglobin were highly active in the upper part of the epidermis. To confirm our findings, we used immunostaining to visualize the presence of hemoglobin ? protein in keratinocytes of the upper epidermis.”
Professor Amagai concludes: “Our study showed that epidermal hemoglobin was upregulated by oxidative stress and inhibited the production of reactive oxygen species in human keratinocyte cell cultures. Our findings suggest that hemoglobin ? protects keratinocytes from oxidative stress derived from external or internal sources such as UV irradiation and impaired mitochondrial function, respectively. Therefore, the expression of hemoglobin by keratinocytes represents an endogenous defense mechanism against skin aging and skin cancer.”

Read more →

Division of cells in cell cultures and cancer

Growth is a fundamental biological process and a prerequisite for living organisms to develop and reproduce. The processes of cell growth (i.e. the production of new biomass) and of cell division must be coordinated with each other.
In multicellular organisms such as humans, the growth of cells must also be coordinated with their environment so that cells are present in the right number and size to form functional tissue or organs. Cell growth is therefore strictly regulated and takes place only when certain growth signals are present.
But cancer cells are different. They grow unchecked, they divide over and over again, and they don’t react to stop signals from their environment.
An advantage can be a disadvantage
Now several studies published in the journal Molecular Cell show that uncontrolled growth is not only an advantage for cancer cells but also a weakness.
One of these studies was led by Professor Gabriel Neurohr from the Institute of Biochemistry at ETH Zurich. For several years, he and his group have been researching how cell growth influences cell function. They are also investigating what happens when cells exceed their normal size and enter a state that the researchers refer to as senescence. In this state, the cells are preternaturally large and lose their ability to divide. Nevertheless, they are still active and can influence their environment, such as by releasing messenger substances.
Senescent cells are found in normal tissue and play an important role in the ageing process. However, senescence can also be induced with chemical substances, and because it leads to a loss of the capacity to divide, it is the goal of certain cancer treatments.

A breakdown in DNA repair
Neurohr’s colleague Sandhya Manohar has now investigated whether excessive size affects cellular functions in senescent cells. In her research, she treated non-cancerous cell line and a breast cancer cell line with substances that inhibit growth and division.
When she used only division-suppressing substances in her cell cultures, the cells were indeed no longer able to divide, but they continued to grow and went into senescence. As a result, they permanently lost their ability to divide. This effect persisted even after Manohar had discontinued the division inhibitors.
An important reason for the loss of the ability to divide is that the enlarged cells can no longer repair damage to their genetic material, such as double-stranded DNA breaks. Such breaks always occur spontaneously when a cell duplicates its genetic material prior to cell division.
In addition, these cells cannot correctly activate a key signalling pathway (p53-p21), which is critical for a coordinated response to DNA breaks. As a result, the damage is not repaired efficiently enough. What this means for enlarged cells is that numerous irreparable DNA breaks accumulate during division — to the point where division is no longer possible.
Is combination therapy counterproductive?
Yet when the researchers treated the cells with division-inhibiting and growth-inhibiting substances simultaneously, the cells were able to divide and multiply normally again after both substances were discontinued. “In cancer therapy, this is precisely what you don’t want,” Neurohr says.

Growth- and division-inhibiting agents are already being used in cancer treatment. “Based on our observations in cell cultures, we would expect an increased relapse rate when treating a tumour with division inhibitors and growth inhibitors at the same time. It would make more sense to first use a division inhibitor, then a drug that further damages the DNA of the cells and makes division completely impossible,” Neurohr explains.
Clinical tests needed to confirm findings
Thus far, the ETH researchers have tested their new findings only on cell cultures. With both growth and division strongly dependent on the cell environment, the team cannot transfer these results directly to a clinical setting. Trials with organoids or on tissue samples are thus needed first to better test the potential treatment. Clinical studies investigating various combinations of division inhibitors and other medications are also underway.
The idea put forth by the ETH researchers under Neurohr has support from studies by three other international research teams, also published in the same issue of Molecular Cell.
These studies show that cancer cells with hyperactive growth are sensitive to treatment with division inhibitors. As these substances are already being used to treat certain types of breast cancer, the new findings could have a long-term impact on cancer treatment.

Read more →

Zimbabwe declares state of emergency in Harare over cholera

Published1 hour agoShareclose panelShare pageCopy linkAbout sharingImage source, ReutersBy Basillioh RukangaBBC NewsZimbabwe has declared a state of emergency in the capital Harare over a cholera outbreak.The outbreak has so far killed dozens of people with more than 7,000 suspected cases.The city authorities say the outbreak, spreading throughout the city, has invoked memories of a deadly outbreak in 2008, in which thousands died.”We have declared a state of emergency because of cholera,” local media quoted Mayor Ian Makone as saying.The authorities are now asking for help to contain the spread and provide safe water, saying the aid being received is inadequate.Health authorities have been struggling to contain the high number of admissions following the outbreak, according to the International Federation of the Red Cross (IFRC).It cites a lack of health workers to manage the cases, as well as lack of supplies to stop the transmission.Zimbabwe has been battling the deadly cholera outbreak in recent months amid a lack of access to clean water.The epicentre of the latest outbreak is Harare’s high-density suburb of Kuwadzana, which accounts for nearly half the reported cases, according to the authorities.Cholera, an acute diarrhoeal infection is caused by consuming food or water contaminated with the bacterium Vibrio cholerae.Zimbabwe’s cholera crisis fuelled by chronic water shortagesOn Thursday, the Harare mayor said the cholera outbreak had similarities to the 2008 outbreak.The outbreak then led to the deaths of over 4,000 people, with at least 100,000 were infected, which led to a paralysis of basic services in the country.This pushed then President Robert Mugabe into agreeing a historic power-sharing deal with his long-time rival, Morgan Tsvangirai.In 2018, the country declared a state of emergency after 20 deaths and more than 2,000 cases related to typhoid and cholera were reported”The cholera outbreak has come with vengeance,” the mayor was quoted as saying on Thursday.On Tuesday, the ministry of health announced that the country had recorded 7,398 suspected cases, 50 confirmed deaths, and 109 people in hospital.It came as the health minister visited the epicentre, announcing measures to deal with the outbreak – including the removal of street food vendors, and trucking of safe water.The IFRC says the disease is quickly spreading, affecting multiple geographical areas in 45 out of 62 districts and in all 10 provinces of the country.It says the outbreak can be expected to cross the border.Neighbouring countries including Malawi, South Africa, and Mozambique have also frequently experienced cholera outbreaks in the past.More Zimbabwe stories from the BBC:Zimbabwe opposition row engulfs Harare mayorBuying banknotes to survive Zimbabwe’s sky-high inflation

Read more →

Al-Shifa Hospital director in Gaza says no water or oxygen left

Published11 hours agoShareclose panelShare pageCopy linkAbout sharingImage source, ReutersThe director of the Gaza Strip’s main hospital raided by Israeli soldiers says the facility has now run out of oxygen and water, and patients “are screaming from thirst”.Muhammad Abu Salmiya said the conditions were “tragic” in Al-Shifa, where there were more than 650 patients, 500 medical staff and 5,000 displaced people.Israeli tanks were surrounding the hospital in Gaza City, he said, with drones buzzing overhead and Israeli soldiers still moving around inside, as their search of the complex lasted a second day.Israel’s army said its operation against Hamas was proceeding in a “discreet, methodical and thorough manner”. However a journalist trapped inside the hospital, Khader, told the BBC’s Rushdi Abu Alouf by phone that Israeli troops were “everywhere, shooting in all directions”.The BBC has not been able to independently verify either of the reports.Since the Israel Defense Forces (IDF) launched their raid on Al-Shifa early on Wednesday, they have released several photos and videos of what they say are Hamas weapons and equipment.On Thursday they said they had found an “operational tunnel shaft and a vehicle containing a large number of weapons”.Mr Abu Salmiya said Israeli troops had blown up Al-Shifa’s main water line.”Sniping operations continue, no-one can move from one building to another, and we have lost communication with our colleagues,” he said.Earlier on Thursday, Khader told the BBC that Israeli troops had “stormed all departments”, destroying the southern part of the building’s wall and dozens of cars.Before Khader’s phone line cut off, he also said that armoured bulldozers had been brought in.Gaza’s Hamas-controlled health ministry reports that Israeli bulldozers “destroyed parts of the southern entrance” of the medical complex.More on Israel-Gaza warFollow live: Latest updatesIn Gaza: Lack of fuel causes blackout across StripReporting: BBC goes inside Al-Shifa hospital with the Israeli armyExplained: The faces of hostages taken from IsraelHistory behind the story: The Israel-Palestinian conflictIsrael launched a major military campaign in the Gaza Strip to destroy Hamas in retaliation for the 7 October cross-border attack by hundreds of gunmen. Israel considers Hamas a terrorist group, as does the UK, US and European Union.At least 1,200 people were killed in Hamas’s assault on Israel and about 240 others were taken hostage.Since Israel started its counter-attack, Gaza’s Hamas-run health ministry has said at least 11,400 people have been killed in the territory and the UN has warned of a “humanitarian disaster”.On Thursday evening, the IDF announced that the body of one of the hostages had been found near Al-Shifa.The IDF identified the victim as Yehudit Weiss, saying she had been kidnapped from her home in Be’eri – a kibbutz in southern Israel.Image source, Family handoutAt the same time, there have been reports of a major phone and internet outage in Gaza believed to have been caused by telecom companies running out of fuel supplies.The IDF said their soldiers were continuing their “complex” operation against Hamas at the hospital.”Soldiers are proceeding one building at a time, searching each floor, all while hundreds of patients and medical staff remain in the complex,” an official said in an update on Thursday evening.The official reiterated the IDF’s claim that there was a “well-hidden terrorist infrastructure in the complex”.Hamas has repeatedly denied that its fighters have been operating inside the hospital.On Thursday, Osama Hamdan, the most senior Hamas leader in Lebanon, ridiculed the Israeli weapons claims, saying that all the arms had been brought in and planted in the hospital by Israelis.Asked by the BBC why progress on talks to release hostages had failed, he said that on three occasions they had been close to a deal but each time it had been stopped by Israeli Prime Minister Benjamin Netanyahu.The Israeli government has not commented on Mr Hamdan’s allegation.In a separate development, Israel has dropped dropped leaflets in the Khan Younis area of southern Gaza, warning people in four towns to evacuate their homes and head to shelters.If that is an indication of an upcoming military operation around the southern city of Khan Younis, it could be a real concern to the hundreds of thousands now sheltering there.Before the war, Khan Younis was home to about 300,000 people – a number that has now grown to one million after Israel urged civilians to move south for their safety.More on this storyBBC goes inside Al-Shifa hospital with the Israeli armyPublished23 hours agoBowen: Hospital raid comes as tone shifts on IsraelPublished1 day agoHow the dead are counted in GazaPublished1 day ago

Read more →

Study proposes new framework to identify keystone microbial species

Microbial communities are thought to contain keystone species, which can disproportionately affect the stability of the communities, even if only present in low abundances. Identifying these keystone species can be challenging, especially in the human gut, since it is not feasible to isolate them through systematic elimination.
Researchers led by a team at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have designed a new data-driven keystone species identification (DKI) framework that uses machine learning to resolve this difficulty.
Using a deep-learning model trained on real human gut microbiome data from a curated metagenomic database, the investigators were able to simulate the removal of any species in any gut microbiome sample. This “thought experiment” enabled them to calculate the “keystoneness” or the relative essentiality of each species in each community.
The scientists found that the predicted keystone species varied across communities. Some scored low median keystoneness across all samples, and were unlikely to be essential to any community. By contrast, those species with high median scores were likely to be keystone in some communities, but not in others. Similar results were also observed from human oral microbiome and environmental microbiomes. These results imply that the notion of keystone microbial species is community specific or context dependent.
Many human gut microbial species are known to have essential functions such as breaking down complex starches or maintaining healthy intestinal environments. The authors were able to use their DKI framework to identify potential keystone species involved in such functions, including one that aids digestion in formula-fed infants and adults.
“Our DKI framework demonstrates the power of machine learning in tackling a fundamental problem in community ecology,” said Yang-Yu Liu, PhD, of the Channing Division of Network Medicine at Brigham and Women’s Hospital. “Our DKI framework can be adapted to facilitate future data-driven work on complex microbial communities.”

Read more →

Genomic tug of war could boost cancer therapy

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine’s effects or become resistant over time. Wilmot Cancer Institute researchers have uncovered a “genomic tug of war” in animal studies that could influence how well certain patients — or certain cancers — respond to decitabine.
In a study published in the journal Development, Wilmot investigators found that decitabine causes different regions of DNA to engage in a tug of war for a gene activator, called H2A.Z. If too little of this gene activator is around, gene expression grinds to a halt, causing cells to die. However, many types of cancer have very high levels of H2A.Z, which may help them overcome this decitabine-induced tug of war, allowing the cancer to grow.
“Two years ago, we published a paper where we identified different subtypes of breast cancer based on the amount of H2A.Z in tumors,” said Patrick Murphy, PhD, assistant professor of Biomedical Genetics and Biology at the University of Rochester Medical Center and member of Wilmot’s Genetics, Epigenetics, and Metabolism program, who led the studies. “If our findings bear out in humans, we may be able to classify patients based on how much H2A.Z is in their tumor, and then decide whether or not this therapy is going to be more or less effective. So it could eventually be used alongside personalized medicine diagnostics.”
H2A.Z is a histone — a class of proteins that DNA wraps around. Different types of histones spool the DNA more tightly, keeping it protected, or loosely, allowing the DNA to be read and turned into proteins that carry out the many functions of a cell.
H2A.Z binds DNA loosely, helping to turn on nearby genes. For a long time, it was believed to only bind to regions of DNA that contain the code for proteins. However, Murphy and postdoctoral associate Fanju Meng, PhD, discovered that H2A.Z also binds to non-coding “junk DNA” in zebrafish.
“That was when we first started wondering, maybe it’s not doing what we think it’s doing, or maybe it’s doing something extra,” said Murphy. “We always thought of H2A.Z as a factor that goes to genes and helps turn them on. So when we started seeing it at different places, we started asking more questions.”
Research dating back to the early 2000’s has hinted at a murky link between H2A.Z and decitabine. More recent studies also show that decitabine can turn on portions of non-coding “junk DNA,” but those studies stopped short of explaining exactly how that happens.

Funded in part by a pilot award from URMC’s Environmental Health Science Center, Murphy and Meng tested the connection between decitabine and H2A.Z using zebrafish embryos. Treating the embryos with decitabine drew H2A.Z toward non-coding regions of DNA, reactivating them, and away from coding DNA, which curtailed gene expression, killed cells, and stunted embryo growth. In embryos that expressed high levels of H2A.Z — mimicking some cancers — there was enough H2A.Z to bind at both coding and non-coding regions and gene expression and embryo development were normal.
The same effect was seen with a toxic chemical, called TDCIPP, which is widely used in flame retardants and pesticides and has been found in human urine and breastmilk. The toxin caused H2A.Z to shift from coding to non-coding DNA regions, reducing gene expression and disrupting embryo development. But embryos that overexpressed H2A.Z were able to overcome the tug of war and were protected from the negative effects of the toxin.
“These external stressors — decitabine and TDCIPP — hijack essential aspects of cellular machinery to cause cell death,” said Murphy. “Our study identifies critical vulnerabilities which can be taken advantage of to improve future cancer therapeutics.”
Further research is needed, however, to confirm that this mechanism also happens in humans and to figure out how junk DNA sequences are able to hijack H2A.Z. As a first step in that direction, Murphy and Meng will soon study this mechanism in mouse embryonic stem cells — making the jump into mammals.

Read more →

How cell identity is preserved when cells divide

Every cell in the human body contains the same genetic instructions, encoded in its DNA. However, out of about 30,000 genes, each cell expresses only those genes that it needs to become a nerve cell, immune cell, or any of the other hundreds of cell types in the body.
Each cell’s fate is largely determined by chemical modifications to the proteins that decorate its DNA; these modification in turn control which genes get turned on or off. When cells copy their DNA to divide, however, they lose half of these modifications, leaving the question: How do cells maintain the memory of what kind of cell they are supposed to be?
A new MIT study proposes a theoretical model that helps explain how these memories are passed from generation to generation when cells divide. The research team suggests that within each cell’s nucleus, the 3D folding pattern of its genome determines which parts of the genome will be marked by these chemical modifications. After a cell copies its DNA, the marks are partially lost, but the 3D folding allows each daughter cell to easily restore the chemical marks needed to maintain its identity. And each time a cell divides, chemical marks allow a cell to restore its 3D folding of its genome. This way, by juggling the memory between 3D folding and the marks, the memory can be preserved over hundreds of cell divisions.
“A key aspect of how cell types differ is that different genes are turned on or off. It’s very difficult to transform one cell type to another because these states are very committed,” says Jeremy Owen PhD ’22, the lead author of the study. “What we have done in this work is develop a simple model that highlights qualitative features of the chemical systems inside cells and how they need to work in order to make memories of gene expression stable.”
Leonid Mirny, a professor in MIT’s Institute for Medical Engineering and Science and the Department of Physics, is the senior author of the paper, which appears today in Science. Former MIT postdoc Dino Osmanovi? is also an author of the study.
Maintaining memory
Within the cell nucleus, DNA is wrapped around proteins called histones, forming a densely packed structure known as chromatin. Histones can display a variety of modifications that help control which genes are expressed in a given cell. These modifications generate “epigenetic memory,” which helps a cell to maintain its cell type. However, how this memory is passed on to daughter cells is somewhat of a mystery.

Previous work by Mirny’s lab has shown that the 3D structure of folded chromosomes is partly determined by these epigenetic modifications, or marks. In particular, they found that certain chromatin regions, with marks telling cells not to read a particular segment of DNA, attract each other and form dense clumps called heterochromatin, which are difficult for the cell to access.
In their new study, Mirny and his colleagues wanted to answer the question of how those epigenetic marks are maintained from generation to generation. They developed a computational model of a polymer with a few marked regions, and saw that these marked regions collapse into each other, forming a dense clump. Then they studied how these marks are lost and gained.
When a cell copies its DNA to divide it between two daughter cells, each copy gets about half of the epigenetic marks. The cell then needs to restore the lost marks before the DNA is passed to the daughter cells, and the way chromosomes were folded serves as a blueprint for where these remaining marks should go.
These modifications are added by specialized enzymes known as “reader-writer” enzymes. Each of these enzymes is specific for a certain mark, and once they “read” existing marks, they “write” additional marks at nearby locations. If the chromatin is already folded into a 3D shape, marks will accumulate in regions that already had modifications inherited from the parent cell.
“There are several lines of evidence that suggest that the spreading can happen in 3D, meaning if there are two parts that are near each other in space, even if they’re not adjacent along the DNA, then spreading can happen from one to another,” Owen says. “That is how the 3D structure can influence the spreading of these marks.”
This process is analogous to the spread of infectious disease, as the more contacts that a chromatin region has with other regions, the more likely it is to be modified, just as an individual who is susceptible to a particular disease is more likely to become infected as their number of contacts increases. In this analogy, dense regions of heterochromatin are like cities where people have many social interactions, while the rest of the genome is comparable to sparsely populated rural areas.

“That essentially means that the marks will be everywhere in the dense region and will be very sparse anywhere outside it,” Mirny says.
The new model suggests possible parallels between epigenetic memories stored in a folded polymer and memories stored in a neural network, he adds. Patterns of marks can be thought of as analogous to the patterns of connections formed between neurons that fire together in a neural network.
“Broadly this suggests that akin to the way neural networks are able to do very complex information processing, the epigenetic memory mechanism we described may be able to process information, not only store it,” he says.
Epigenetic erosion
While this model appeared to offer a good explanation for how epigenetic memory can be maintained, the researchers found that eventually, reader-writer enzyme activity would lead to the entire genome being covered in epigenetic modifications. When they altered the model to make the enzyme weaker, it didn’t cover enough of the genome and memories were lost in a few cell generations.
To get the model to more accurately account for the preservation of epigenetic marks, the researchers added another element: limiting the amount of reader-writer enzyme available. They found that if the amount of enzyme was kept between 0.1 and 1 percent of the number of histones (a percentage based on estimates of the actual abundance of these enzymes), their model cells could accurately maintain their epigenetic memory for up to hundreds of generations, depending on the complexity of the epigenetic pattern.
It is already known that cells begin to lose their epigenetic memory as they age, and the researchers now plan to study whether the process they described in this paper might play a role in epigenetic erosion and loss of cell identity. They also plan to model a disease called progeria, in which cells have a genetic mutation that leads to loss of heterochromatin. People with this disease experience accelerated aging.
“The mechanistic link between these mutations and the epigenetic changes that eventually happen is not well understood,” Owen says. “It would be great to use a model like ours where there are dynamic marks, together with polymer dynamics, to try and explain that.”
The researchers also hope to work with collaborators to experimentally test some of the predictions of their model, which could be done by altering the level of reader-writer enzymes in living cells and measuring the effect on epigenetic memory.
The research was funded by the National Human Genome Research Institute, the National Institute of General Medical Sciences, and the National Science Foundation.

Read more →

Hunger hormones impact decision-making brain area to drive behavior

A hunger hormone produced in the gut can directly impact a decision-making part of the brain in order to drive an animal’s behaviour, finds a new study by UCL (University College London) researchers.
The study in mice, published in Neuron, is the first to show how hunger hormones can directly impact activity of the brain’s hippocampus when an animal is considering food.
Lead author Dr Andrew MacAskill (UCL Neuroscience, Physiology & Pharmacology) said: “We all know our decisions can be deeply influenced by our hunger, as food has a different meaning depending on whether we are hungry or full. Just think of how much you might buy when grocery shopping on an empty stomach. But what may seem like a simple concept is actually very complicated in reality; it requires the ability to use what’s called ‘contextual learning’.
“We found that a part of the brain that is crucial for decision-making is surprisingly sensitive to the levels of hunger hormones produced in our gut, which we believe is helping our brains to contextualise our eating choices.”
For the study, the researchers put mice in an arena that had some food, and looked at how the mice acted when they were hungry or full, while imaging their brains in real time to investigate neural activity. All of the mice spent time investigating the food, but only the hungry animals would then begin eating.
The researchers were focusing on brain activity in the ventral hippocampus (the underside of the hippocampus), a decision-making part of the brain which is understood to help us form and use memories to guide our behaviour.
The scientists found that activity in a subset of brain cells in the ventral hippocampus increased when animals approached food, and this activity inhibited the animal from eating.

But if the mouse was hungry, there was less neural activity in this area, so the hippocampus no longer stopped the animal from eating. The researchers found this corresponded to high levels of the hunger hormone ghrelin circulating in the blood.
Adding further clarity, the UCL researchers were able to experimentally make mice behave as if they were full, by activating these ventral hippocampal neurons, leading animals to stop eating even if they were hungry. The scientists achieved this result again by removing the receptors for the hunger hormone ghrelin from these neurons.
Prior studies have shown that the hippocampus of animals, including non-human primates, has receptors for ghrelin, but there was scant evidence for how these receptors work.
This finding has demonstrated how ghrelin receptors in the brain are put to use, showing the hunger hormone can cross the blood-brain barrier (which strictly restricts many substances in the blood from reaching the brain) and directly impact the brain to drive activity, controlling a circuit in the brain that is likely to be the same or similar in humans.
Dr MacAskill added: “It appears that the hippocampus puts the brakes on an animal’s instinct to eat when it encounters food, to ensure that the animal does not overeat — but if the animal is indeed hungry, hormones will direct the brain to switch off the brakes, so the animal goes ahead and begins eating.”
The scientists are continuing their research by investigating whether hunger can impact learning or memory, by seeing if mice perform non-food-specific tasks differently depending on how hungry they are. They say additional research might also shed light on whether there are similar mechanisms at play for stress or thirst.
The researchers hope their findings could contribute to research into the mechanisms of eating disorders, to see if ghrelin receptors in the hippocampus might be implicated, as well as with other links between diet and other health outcomes such as risk of mental illnesses.
First author Dr Ryan Wee (UCL Neuroscience, Physiology & Pharmacology) said: “Being able to make decisions based on how hungry we are is very important. If this goes wrong it can lead to serious health problems. We hope that by improving our understanding of how this works in the brain, we might be able to aid in the prevention and treatment of eating disorders.”

Read more →